Access free, up-to-date clinical references for comprehensive information on assessing multiple sclerosis at Healio. Our content provides valuable insights for physicians.

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

A new study by researchers in the Department of Clinical Neuroscience, Karolinska Institutet, has identified 18 potential ...

Multiple sclerosis (MS) is a common immune-mediated progressive neurodegenerative disease of the CNS that typically manifests with periods of disease activity followed by intervals of remission ...

Anti-CD20 therapies, a type of MS treatment, changes levels and profiles of several immune cells in people with MS, a study ...

A trial using PET scans to test the anti-inflammatory drug PIPE-791 finished enrolling healthy volunteers and patients with ...

“To test MindGlide’s generalizability across ages 14–64, we employed an external validation set of two progressive MS clinical trials, and a real-world cohort of pediatric relapsing ...

VANCOUVER, BC / ACCESS Newswire / July 7, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC:XPHYF)(FSE:4XT), a bioscience innovator specializing in advanced drug delivery systems ...

The quest to mitigate disability progression in multiple sclerosis (MS) has long been hindered by our limited understanding ...

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with their disorder, a new clinical trial suggests. The drug, tolebrutinib ...

Access free, up-to-date clinical guidance on Multiple Sclerosis at Healio. We offer valuable insights for identifying, assessing, treating, and managing this condition.